Alpha Teknova (TKNO) Preferred Stock Liabilities (2020)

Alpha Teknova (TKNO) reported Preferred Stock Liabilities of $35.6 million for Q4 2020.

Alpha Teknova (TKNO) Preferred Stock Liabilities (2020) Analysis & Trends

Alpha Teknova (TKNO) has 1 years of Preferred Stock Liabilities data on file, last reported at $35.6 million in Q4 2020.

  • Preferred Stock Liabilities for Q4 2020 came in at $35.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $35.6 million (changed N/A YoY), and the FY2020 annual result was $35.6 million, changed N/A from the prior year.
  • Preferred Stock Liabilities was little changed at $35.6 million in Q4 2020 per TKNO's latest filing.
  • Over five years, Preferred Stock Liabilities peaked at $35.6 million in Q4 2020 and troughed at $35.6 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Alpha Teknova 239.62 Mn 221.84 Mn 3.78 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 35.64 Mn